SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$29.68−1.75 (-5.58%)
Close on Nov 18, 2026Market cap $992.74MP/E –Yield –
SpyGlass Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for SpyGlass Pharma
SpyGlass Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?